Positive Effects of Pimavanserin for Patients With AD: Clive Ballard, MD
July 29th 2021Clive Ballard, MD, professor of age related diseases at University of Exeter, commented on the potential impact that the approval of pimavanserin would have for patients if approved for dementia-related psychosis.
Researching Posttraumatic Headache With Cranial Neuralgias: Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
July 27th 2021The assistant professor of neurology at Harvard Medical School discussed the motivation behind uncovering more about painful cranial neuralgias and their association with posttraumatic headache.
Stroke Systems of Care: Mitchell S.V. Elkind, MD, MS, MPhil
July 26th 2021Following the publication of new guidelines for the care of adults poststroke, the president of the American Heart Association commented on streamlining systems of care to manage acute stroke and foster long-term prevention.
Research in Alzheimer Disease and Dementia: Jessica Zwerling, MD, MS
July 25th 2021The director of Montefiore Hudson Valley Center of Excellence for Alzheimer’s Disease, associate professor of neurology, Albert Einstein College of Medicine, discussed recent developments in Alzheimer disease research, including FDA approval of aducanumab, as well as the importance of engaging community-based organizations to improve patient care.
Device-Assisted Therapy in Advanced Parkinson Disease Management
A discussion about when a clinician should consider discussing a device-assisted therapy with a patient with advanced Parkinson disease.
Anti-CD20 Agents for Relapsing MS
A panel of experts discuss the use of anti-CD20 monoclonal antibodies in relapsing multiple sclerosis including summaries of the phase III ORATORIO and ASCLEPIOS trials, for ocrelizumab and ofatumumab, respectively.
Advanced Parkinson Disease: New Technology in Practice
A discussion about when a clinician should consider discussing a device-assisted therapy with a patient with advanced Parkinson disease.
Changes to Sleep Care Throughout the COVID-19 Pandemic: Michael Thorpy, MD
July 22nd 2021The director of the Sleep-Wake Disorders Center at Montefiore Medical Center discussed the adjustments clinicians and patients with sleep disorders made throughout the pandemic, including the increased use of telemedicine.
Telehealth and Trial Recruitment in Alzheimer Disease: Jessica Zwerling, MD, MS
July 22nd 2021In Alzheimer disease and dementia, Jessica Zwerling, MD, MS, director, Montefiore Hudson Valley Center of Excellence for Alzheimer’s Disease, believes normalizing trial recruitment aids and telehealth to increase participation is another way to ease delivery of care.